Hosted on MSN
Nanotech makes a cancer drug 20,000 times stronger
Recent scientific advancements have led to the development of a nanotechnology-based cancer drug that is 20,000 times more potent than its predecessors, yet remarkably, it exhibits no detectable side ...
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...
Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy. A team of ...
Jacob Berlin, PhD, CEO of Terray Therapeutics, explains that the critical element to “get right” for a preclinical drug discovery campaign is identifying molecules that rank best among the candidate ...
Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...
The pharmaceutical industry is a pillar of global health, valued at over $1.5 trillion. Within this sector, Analytical Research and Development (AR&D) ensures drug quality, safety, and efficacy. AR&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results